Pharmafile Logo
Pharmafocus logo
Advanced Search
iclusig image

Ariad ditches CML trial

October 21, 2013
Research and Development, Sales and Marketing Ariad, CML, iclusig

Ariad Pharmaceuticals has ditched its late-stage trial of Iclusig in patients with newly-diagnosed chronic myeloid leukemia (CML) after blood clots …

News
Eisai image

Eisai: reform NICE or we’ll pull out of the UK

October 21, 2013
Research and Development, Sales and Marketing Eisai, Hatfield, Hunt, NICE

Eisai has criticised NICE for being too narrow minded on assessing new drugs, and has warned it may pull its …

News

No closer to Alzheimer’s cure despite rise in research

October 21, 2013
Research and Development, Sales and Marketing Alzheimer's, depression, markram

A scientist charged with developing a digital model of the human brain has said that patients with neurological and neurodegenerative …

News
Herceptin image

The new paradigm in oncology drug marketing

October 21, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Herceptin, Roche, marketing, oncology

Twenty years ago drugs to treat cancer were made up of chemotherapy agents which are essentially ‘blunt tools’ against the …

Feature
jacek_glinka_mylan

Mylan hires president of European business

October 21, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, glinka

Mylan has announced that from December Jacek Glinka will be the president of its European business. Glinka served as chief …

Appointment
fda image

Dust settles on US shutdown

October 21, 2013
Medical Communications, Sales and Marketing FDA, Obamacare, PhRMA, shutdown

The FDA has said that it was able to carry out a significant part of its remit during the suspension …

News
wockhardt image

MHRA recalls five Wockhardt medicines

October 18, 2013
Manufacturing and Production FDA, GMP, MHRA, Violations, Wockhardt, recall

The UK drugs regulator has recalled five more generic medicines made by Indian drugmaker Wockhardt after an inspection uncovered quality …

News
Adderall image

Shire slated following Adderall T-shirt controversy

October 18, 2013
Medical Communications, Sales and Marketing Adderall, EMA, FDA, Shire

A senior doctor and patient welfare advocate has criticised Shire after T-shirts emblazoned with the word ‘Adderall’ appeared for sale …

News
Roche image

Roche rules out merger talk

October 18, 2013
Sales and Marketing Cancer, Herceptin, Novartis, Roche, merger

Roche has dismissed talk of merging with fellow Swiss manufacturer Novartis as it revealed its results for the last three …

News
web_simon_bellamy_scm

SCM Pharma appoints new director

October 18, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing SCM Pharma, simon bellamy

Contract development and manufacturing organisation SCM Pharma has expanded its commercial management team with the appointment of a new director. …

Appointment

Astellas gets NICE nod

October 18, 2013
Sales and Marketing Cancer, NHS, NICE, Xtandi

Astellas Pharma’s new prostate cancer drug Xtandi which has been shown to shrink and kill cancer cells, has been recommended …

News
GSK China image

Travel ban ambiguity for GSK ‘s former China boss

October 17, 2013
Sales and Marketing China, GSK, bribery, reilly

GlaxoSmithKline has refuted reports that its former chief of Chinese operations is barred from leaving the country while he assists …

News
Quest diagnostics image

Quest starts selling BRCA tests

October 17, 2013
Sales and Marketing BRCA, Myriad, Quest, jolie

Quest Diagnostics has begun selling a genetic test to uncover the risk of hereditary breast cancer, after the US Supreme …

News

SHL to Inspire Innovation at the 2013 PDA Conference in Basel, Switzerland

October 17, 2013
Manufacturing and Production auto injector, auto-injector, autoinjector, autoinjector innovation, pen injector, shl pda basel

 

News
Press release

GCI Health expands with new London office

October 17, 2013
Medical Communications GCI Health, agency, comms

Healthcare communications agency GCI Health has officially opened its London office. The expansion, in response to the agency’s growing global …

News
HPV vaccine image

GAVI begins roll-out of cheap HPV vaccine

October 17, 2013
Sales and Marketing GAVI, HPV, Vaccine

For the first time women in parts of the world with the highest cervical cancer death rate will be able …

News
screen_shot_2013-10-17_at_08

Director appointed for MediCity

October 17, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing browning, medicity

Former chief executive of Philips Healthcare and Consumer Lifestyle David Browning has been appointed director of MediCity. The new Nottingham-based …

Appointment
Regeneron image

Phase III boost for alirocumab

October 17, 2013
Sales and Marketing LDL, Regeneron, alirocumab

Sanofi and Regeneron Pharmaceuticals are celebrating some upbeat data from their investigational treatment alirocumab, which has proved adept at tackling …

News
NHS image

Patients should ‘top up’ NHS costs

October 16, 2013
Sales and Marketing Dixon, England, NHS, NICE, top up

A leading doctor believes that NHS patients must produce top up payments for treatments for non-life threatening conditions. Speaking at …

News

Rare disease fund scrapped by NHS England

October 16, 2013
Research and Development, Sales and Marketing NHS England, fund, rare diseases

NHS England has pulled the plug on a £50 million fund to advance innovation in the investigation and treatment of …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026